The Valley Desk

ArticleNeuro-oncology advancesPublished

Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Neuro-oncology advances
Published
Subject terms
Radiation; Glioblastoma; Microtubule Inhibitor; Lisavanbulin; Mgmt Promoter Unmethylated
PubMed ID
39371261
PubMed Central ID
PMC11450402
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal